PGIM Jennison Health Sciences Fund highlighted stocks like Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), in the second quarter ...
In a report released today, Derek Archila from Wells Fargo maintained a Hold rating on Apellis Pharmaceuticals (APLS – Research Report), with a price target of $43.00. The company’s shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback